A Phase IIa Study Investigating the Tolerance, Efficacy and Safety of HSK3486

NCT03698617 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

114

Enrollment

INDUSTRY

Sponsor class

Conditions

Induction of General Anaesthesia

Interventions

DRUG: HSK3486
DRUG: Propofol

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd